Eplerenon (Inspra®), behandeling linkerventrikeldysfunctie


1. Pitt B, et al. Eplerenone, a selective aldosterone blocker in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-1321.
2. Jessup M. Aldosterone blockade and heart failure. N Engl J Med 2004; 348: 1380-1382.
3. Stier CT, et al. Aldosterone and aldosterone antagonism in cardiovascular disease: focus on eplerenone. Heart Dis 2003; 5: 102-118.
4. Pitt B, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl Med J 1999; 341: 709-717.
5. 1B-tekst eplerenon (Inspra®) via: www.cbg.nl, Geneesmiddeleninformatiebank.
6. Multidisciplinaire richtlijn chronisch hartfalen. 
7. NHG-Standaard hartfalen. Huisarts Wet 2005; 48: 64-76.    

Auteurs

  • dr J.J. Beckeringh